During the past decade, Lowcountry Hematology Oncology PA-Mount Pleasant conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 29 clinical trials were completed, i.e. on average, 120.8% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 24 clinical trials were completed. i.e. 2400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lowcountry Hematology Oncology PA-Mount Pleasant" #1 sponsor was "National Cancer Institute (NCI)" with 17 trials, followed by "SWOG Cancer Research Network" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lowcountry Hematology Oncology PA-Mount Pleasant" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Biologics, Inc." with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Lowcountry Hematology Oncology PA-Mount Pleasant" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Breast Cancer" (3 trials), "Recurrent Breast Carcinoma" (3 trials) and "Recurrent Melanoma" (3 trials). Many other conditions were trialed in "Lowcountry Hematology Oncology PA-Mount Pleasant" in a lesser frequency.

Most popular intervention types in "Lowcountry Hematology Oncology PA-Mount Pleasant" are "Drug" (38 trials), "Other" (31 trials), "Biological" (16 trials), "Procedure" (6 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Quality-of-Life Assessment" (9 trials), "Ipilimumab" (6 trials), "Docetaxel" (5 trials) and "Nivolumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Lowcountry Hematology Oncology PA-Mount Pleasant" are 35 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Lowcountry Hematology Oncology PA-Mount Pleasant". undefined are not yet recruiting, 4 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Lowcountry Hematology Oncology PA-Mount Pleasant, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Lowcountry Hematology Oncology PA-Mount Pleasant, 0 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".